Clinical Benefit From Pemetrexed Before and After Crizotinib Exposure and From Crizotinib Before and After Pemetrexed Exposure in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer
| Autor: | Berge, Eamon M. 1, ∗, Lu, Xian 2, Maxson, Delee 1, Barón, Anna E. 2, Gadgeel, Shirish M. 3, Solomon, Benjamin J. 4, Doebele, Robert C. 1, Varella-Garcia, Maria 1, Camidge, D. Ross 1 |
|---|---|
| Zdroj: | In Clinical Lung Cancer November 2013 14(6):636-643 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect